The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Neptune Tech & Bioresources

  • NTB
  • TSX
  • Consumer Products
  • Latest 2.85
  • Currency C$
  • Change -0.09
  • Percent Change -3.061 %
  • Volume 66,974
  • Fri May 24, 2013 3:59 PM EDT TSX data delayed 15 minutes.
  • Open 2.88
  • Previous Close 2.94
  • High 2.90
  • Low 2.81
  • Bidx5 2.83
  • Askx12 2.88
  • 52-week High 07/31 5.05
  • 52-week Low 12/18 1.59
  • Beta 2.43
  • Market Cap 142.96M
  • EPS -0.10
  • P/E --
  • Forward P/E --
  • PEG --
  • Annual Dividend --
  • Yield --

News

Financials & Calendars

Income Statement

  • Sales $25,292,914
  • Earnings $-4,892,015
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-2,139,294
  • Cash $3,817,180
  • Current Ratio 2.37

12 months ended Aug 31, 2012.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $49,265,375
  • Liabilities $18,885,449
  • Liabilities-to-Equity Ratio 0.62

Price Ratios

  • Price to Sales 5.63
  • Price to Book 4.67
  • Price to Cash Flow -66.57

Event Calendar

Event Last   Next  
Earnings May 16 n/a Jul 16 n/a
Surprises Jan 15 60.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended May 24, 2013.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. researches and develops bioactive marine ingredients for the global nutraceutical and pharmaceutical markets.

Related Securities
Symbol Type Latest % Chg

Officers

  • Henri Harland President & C.E.O. & Corp. Sec
  • Andre Godin C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 74
  • Incorporation: Canada,
    Oct 9, 1998
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

545 Promenade du Centropolis
Laval, QC
H7T 0A3

Phone: (450)-687-2262
Fax: (450)-6872272

info@neptunebiotech.com
www.neptunebiotech.com

Ideas & Discussion

Live Discussion of NTB on StockTwits